Vector Development
Hybrid Vector Is a Simple and Effective Gene Transfer Vehicle
Published in Gene Therapy Weekly, February 17th, 1997
Suming Wang and Jean-Michel Vos from the University of North Carolina have developed an infectious miniviral vector based on Epstein-Barr virus (EBV) and herpes simplex virus type 1 (HSV-1) which shows potential for use as a cancer and inherited gene therapy vector ("A Hybrid Herpesvirus Infectious Vector Based on Epstein-Barr Virus and Herpes Simplex Virus Type 1 for Gene Transfer into Human Cells In Vitro and In Vivo," Journal of Virology, December 1996;70(12):8422-30).
"In this study, we present a novel EBV/HSV-based miniviral...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1997-02-17)
More Articles from Gene Therapy Weekly
- Ribozyme Therapy
Hammerhead Ribozymes Exhibit Potential Gene Therapy Uses - Cancer Gene Therapy
FDA Clearance Received To Commence Phase I IL-2 Cancer Trial - Cancer Gene Therapy
Targeting of Melanoma Cells Possible with Recombinant Adenoviruses - Animal Models
Human Antibody Genes Introduced Into Antibody-Producing Mouse Strain - Antisense Technology
Tumorigenesis Inhibited by Cytosine-DNA MeTase Antisense Therapy - Brain Cancer
Identification of Cancer Gene Announced - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
